• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants. Reply.

作者信息

Kampmann Beate, Radley David, Munjal Iona

机构信息

MRC Unit the Gambia at the London School of Hygiene and Tropical Medicine, Fajara, Gambia.

Pfizer, Pearl River, NY

出版信息

N Engl J Med. 2023 Sep 14;389(11):1053-1055. doi: 10.1056/NEJMc2307729.

DOI:10.1056/NEJMc2307729
PMID:37703563
Abstract
摘要

相似文献

1
Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants. Reply.孕期接种二价预融合F疫苗预防婴儿呼吸道合胞病毒疾病。回复。
N Engl J Med. 2023 Sep 14;389(11):1053-1055. doi: 10.1056/NEJMc2307729.
2
Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants. Reply.孕期接种二价预融合F疫苗预防婴儿呼吸道合胞病毒疾病。回复。
N Engl J Med. 2023 Sep 14;389(11):1055. doi: 10.1056/NEJMc2307729.
3
Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants.孕期接种二价融合前F疫苗预防婴儿呼吸道合胞病毒疾病
N Engl J Med. 2023 Apr 20;388(16):1451-1464. doi: 10.1056/NEJMoa2216480. Epub 2023 Apr 5.
4
Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants.孕期接种二价预融合F疫苗预防婴儿呼吸道合胞病毒疾病
N Engl J Med. 2023 Sep 14;389(11):1053. doi: 10.1056/NEJMc2307729.
5
Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants.孕期接种二价预融合F疫苗预防婴儿呼吸道合胞病毒疾病
N Engl J Med. 2023 Sep 14;389(11):1052-1053. doi: 10.1056/NEJMc2307729.
6
Bivalent prefusion F vaccination in pregnancy and respiratory syncytial virus hospitalisation in infants in the UK: results of a multicentre, test-negative, case-control study.英国孕期二价预融合F疫苗接种与婴儿呼吸道合胞病毒住院情况：一项多中心、检测阴性的病例对照研究结果
Lancet Child Adolesc Health. 2025 Jul 18. doi: 10.1016/S2352-4642(25)00155-5.
7
Budget impact of maternal vaccination with RSVpreF to protect privately insured infants in Dubai against respiratory syncytial virus.使用呼吸道合胞病毒融合前体蛋白（RSVpreF）对迪拜的私人保险婴儿进行母体疫苗接种以预防呼吸道合胞病毒的预算影响。
Hum Vaccin Immunother. 2025 Dec;21(1):2523106. doi: 10.1080/21645515.2025.2523106. Epub 2025 Jul 2.
8
Burden of respiratory syncytial virus disease in infants and the potential value of maternal immunization in Greece.希腊婴儿呼吸道合胞病毒疾病负担及母体免疫的潜在价值。
Front Public Health. 2025 Jul 16;13:1611483. doi: 10.3389/fpubh.2025.1611483. eCollection 2025.
9
Respiratory Syncytial Virus Vaccine and Nirsevimab Uptake Among Pregnant People and Their Neonates.呼吸道合胞病毒疫苗及尼塞韦单抗在孕妇及其新生儿中的接种情况
JAMA Netw Open. 2025 Feb 3;8(2):e2460735. doi: 10.1001/jamanetworkopen.2024.60735.
10
Respiratory Syncytial Virus Prefusion F Subunit Vaccine: First Approval of a Maternal Vaccine to Protect Infants.呼吸道合胞病毒融合前 F 亚单位疫苗：首个保护婴儿的母体疫苗的批准。
Paediatr Drugs. 2023 Nov;25(6):729-734. doi: 10.1007/s40272-023-00598-3.

引用本文的文献

1
Pediatric respiratory syncytial virus rehospitalization rate - a retrospective observational study from Switzerland.小儿呼吸道合胞病毒再住院率——一项来自瑞士的回顾性观察研究
BMC Pediatr. 2025 Jul 12;25(1):550. doi: 10.1186/s12887-025-05887-z.
2
The Impact of -Associated Junction Plakoglobin on Respiratory Syncytial Virus Infection.与连环蛋白相关的桥粒珠蛋白对呼吸道合胞病毒感染的影响。
Viruses. 2025 Apr 26;17(5):627. doi: 10.3390/v17050627.
3
A single amino acid mutation alters multiple neutralization epitopes in the respiratory syncytial virus fusion glycoprotein.
单个氨基酸突变改变呼吸道合胞病毒融合糖蛋白中的多个中和表位。
Npj Viruses. 2025 Apr 22;3(1):33. doi: 10.1038/s44298-025-00119-8.
4
Favorable Nonclinical Safety Profile of RSVpreF Bivalent Vaccine in Rats and Rabbits.呼吸道合胞病毒前融合蛋白二价疫苗在大鼠和兔子中的良好非临床安全性概况。
Vaccines (Basel). 2024 Dec 31;13(1):26. doi: 10.3390/vaccines13010026.
5
Study of Children Aged Under 2 Years Admitted With RSV at Four Australian Hospitals [2021-2022].澳大利亚四家医院2021 - 2022年收治的2岁以下呼吸道合胞病毒感染患儿的研究
J Paediatr Child Health. 2025 Mar;61(3):482-490. doi: 10.1111/jpc.16769. Epub 2025 Jan 18.
6
Impact of Viral Lower Respiratory Tract Infection (LRTI) in Early Childhood (0-2 Years) on Lung Growth and Development and Lifelong Trajectories of Pulmonary Health: A National Institutes of Health (NIH) Workshop Summary.幼儿期（0 - 2岁）病毒性下呼吸道感染（LRTI）对肺生长发育及肺部健康终身轨迹的影响：美国国立卫生研究院（NIH）研讨会总结
Pediatr Pulmonol. 2025 Jan;60(1):e27357. doi: 10.1002/ppul.27357. Epub 2024 Nov 20.
7
Role of Poly(A)-Binding Protein Cytoplasmic 1, a tRNA-Derived RNA Fragment-Bound Protein, in Respiratory Syncytial Virus Infection.聚腺苷酸结合蛋白细胞质1（一种与tRNA衍生RNA片段结合的蛋白）在呼吸道合胞病毒感染中的作用
Pathogens. 2024 Sep 12;13(9):791. doi: 10.3390/pathogens13090791.
8
Postpandemic fluctuations of regional respiratory syncytial virus hospitalization epidemiology: potential impact on an immunization program in Switzerland.大流行后区域呼吸道合胞病毒住院流行病学波动：对瑞士免疫计划的潜在影响。
Eur J Pediatr. 2024 Dec;183(12):5149-5161. doi: 10.1007/s00431-024-05785-z. Epub 2024 Sep 27.
9
Respiratory Syncytial Virus Hospitalizations Associated With Social Vulnerability by Census Tract: An Opportunity for Intervention?按普查区划分的与社会脆弱性相关的呼吸道合胞病毒住院情况：干预的契机？
Open Forum Infect Dis. 2024 Mar 29;11(5):ofae184. doi: 10.1093/ofid/ofae184. eCollection 2024 May.
10
Engineered dityrosine-bonding of the RSV prefusion F protein imparts stability and potency advantages.工程化的 RSV 预融合 F 蛋白二酪氨酸键赋予了稳定性和效力优势。
Nat Commun. 2024 Mar 14;15(1):2202. doi: 10.1038/s41467-024-46295-8.